Bretovameran

5 trials 2 recruiting JAnti-infectives

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

2 Recruiting

2 Completed trials

6 Sponsors

4 Countries

Phase IV

Phase I (FiH)

Phase IV: 4 Phase I (FiH): 1

Indications tested

COVID-19 2 Fibrodysplasia ossificans progressiva 1

Sponsors using this IMP

Amsterdam UMC Stichting 1 Centre Hospitalier Regional Universitaire De Tours 1 Finnish Institute For Health And Welfare 1 Inserm 1 Sciensano 1 University Of Antwerp 1

All trials

5 total

LONGITUDINAL FOLLOW-UP OF SARS-COV-2 IMMUNITY IN IMMUNOCOMPROMISED POPULATIONS IN BELGIUM (COVICO) A non-commercial multicenter academic pro… Pending

2024-518098-33-01 Phase IV 1 country Sciensano
Randomized, controlled, multicenter Phase I/II study comparing the safety and immunogenicity of a booster dose of an intranasal COVID-19 vac… Recruiting

2024-510589-17-00 Phase I (FiH) 1 country Centre Hospitalier Regional Universitaire De Tours; Inserm
Safety and efficacy of intradermal mRNA SARS-CoV-2 vaccination in patients with Fibrodysplasia Ossificans Progressiva (IVY trial) Recruiting

2024-518686-10-00 Phase IV 1 country Amsterdam UMC Stichting
A phase 4, open-label study to evaluate the short-term innate immune response after administration of a COVID-19 mRNA vaccine (Comirnaty JN… Ended

2024-520304-26-00 Phase IV 1 country University Of Antwerp
COVID-19 vaccine immunology Ended

2024-517357-27-00 Phase IV 1 country Finnish Institute For Health And Welfare

Showing 1–5 of 5 trials

← All drugs A–Z